Akso Health Group ADR (AHG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | 5,533 | N/A | N/A |
| Depreciation Amortization | N/A | N/A | 407 | N/A | N/A |
| Income taxes - deferred | N/A | N/A | -3,724 | N/A | N/A |
| Accounts receivable | N/A | N/A | -419 | N/A | N/A |
| Other Working Capital | N/A | N/A | -11,621 | N/A | N/A |
| Other Operating Activity | 0 | 0 | 8,093 | 0 | 0 |
| Operating Cash Flow | $N/A | $N/A | $-1,731 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -50,667 | N/A | N/A |
| PPE Investments | N/A | N/A | -939 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -16,501 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $-68,107 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 20,000 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 1,157 | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -1,321 | N/A | N/A |
| Dividend Paid | N/A | N/A | -19,548 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -318 | 0 | 0 |
| Financing Cash Flow | $N/A | $N/A | $-29 | $N/A | $N/A |
| Exchange Rate Effect | N/A | N/A | -5,383 | N/A | N/A |
| Beginning Cash Position | N/A | N/A | 132,623 | N/A | N/A |
| End Cash Position | N/A | N/A | 57,372 | N/A | N/A |
| Net Cash Flow | $N/A | $N/A | $-75,250 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | -1,731 | N/A | N/A |
| Capital Expenditure | N/A | N/A | -945 | N/A | N/A |
| Free Cash Flow | 0 | 0 | -2,676 | 0 | 0 |